secwatch.observer — SEC 8-K summary
======================================

Issuer:     PLUS THERAPEUTICS, INC. (PSTV)
CIK:        0001095981
Form:       8-K
Filed at:   2025-08-14T23:59:59+00:00
Accession:  0001193125-25-180814
Event type: other
Sentiment:  positive
Materiality: 0.70
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Plus Therapeutics Regains Nasdaq Compliance; Reports $3M Stockholders' Equity and $35M+ MVLS
--------------------------------------------------------------------------------

- Reported stockholders' equity of $3M as of June 30, 2025, satisfying Nasdaq's minimum $2.5M Equity Rule.
- Sold over $2M in common stock via a $50M equity line of credit with Lincoln Park Capital Fund since June 30.
- As of August 13, 2025, market value of listed securities exceeded $35M for 20 consecutive business days, meeting the alternative MVLS requirement.
- Company awaits formal Nasdaq confirmation that it has evidenced compliance with either or both listing standards.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1095981/000119312525180814/0001193125-25-180814-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1095981/000119312525180814/d824499d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-180814

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer